Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-31

FDA Approved: ANAGRELIDE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for ANAGRELIDE from Chartwell RX, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ANAGRELIDE (Anagrelide)

Snippet

SUPPL AP for ANAGRELIDE (ANAGRELIDE)